201 related articles for article (PubMed ID: 22506056)
1. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
2. The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.
Irvine JC; Ganthavee V; Love JE; Alexander AE; Horowitz JD; Stasch JP; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(11):e44481. PubMed ID: 23144773
[TBL] [Abstract][Full Text] [Related]
3. HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.
Irvine JC; Cao N; Gossain S; Alexander AE; Love JE; Qin C; Horowitz JD; Kemp-Harper BK; Ritchie RH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H365-77. PubMed ID: 23729209
[TBL] [Abstract][Full Text] [Related]
4. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.
Chin KY; Qin C; Cao N; Kemp-Harper BK; Woodman OL; Ritchie RH
Br J Pharmacol; 2014 Apr; 171(7):1722-34. PubMed ID: 24372173
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
[TBL] [Abstract][Full Text] [Related]
6. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
7. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature.
Favaloro JL; Kemp-Harper BK
Cardiovasc Res; 2007 Feb; 73(3):587-96. PubMed ID: 17189622
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt.
Zeller A; Wenzl MV; Beretta M; Stessel H; Russwurm M; Koesling D; Schmidt K; Mayer B
Mol Pharmacol; 2009 Nov; 76(5):1115-22. PubMed ID: 19720727
[TBL] [Abstract][Full Text] [Related]
9. Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity.
Miller AA; Maxwell KF; Chrissobolis S; Bullen ML; Ku JM; Michael De Silva T; Selemidis S; Hooker EU; Drummond GR; Sobey CG; Kemp-Harper BK
Free Radic Biol Med; 2013 Jul; 60():264-71. PubMed ID: 23459072
[TBL] [Abstract][Full Text] [Related]
10. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
[TBL] [Abstract][Full Text] [Related]
11. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
[TBL] [Abstract][Full Text] [Related]
12. Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms.
Favaloro JL; Kemp-Harper BK
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1274-80. PubMed ID: 19252101
[TBL] [Abstract][Full Text] [Related]
13. Nitrite- and nitroxyl-induced relaxation in porcine coronary (micro-) arteries: underlying mechanisms and role as endothelium-derived hyperpolarizing factor(s).
Botden IP; Batenburg WW; de Vries R; Langendonk JG; Sijbrands EJ; Danser AH
Pharmacol Res; 2012 Nov; 66(5):409-18. PubMed ID: 22902525
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes.
Laskowski A; Woodman OL; Cao AH; Drummond GR; Marshall T; Kaye DM; Ritchie RH
Cardiovasc Res; 2006 Oct; 72(1):112-23. PubMed ID: 16890211
[TBL] [Abstract][Full Text] [Related]
15. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
[TBL] [Abstract][Full Text] [Related]
16. Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses.
Wynne BM; Labazi H; Tostes RC; Webb RC
Pharmacol Res; 2012 Jan; 65(1):41-7. PubMed ID: 21767645
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
18. HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways.
Zhou Y; Wu Z; Cao X; Ding L; Wen Z; Bian JS
Pharmacol Res; 2016 Sep; 111():885-895. PubMed ID: 27507578
[TBL] [Abstract][Full Text] [Related]
19. The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat.
Liu K; Deng X; Gong L; Chen X; Wang S; Chen H; Chen X; Amrit B; He S
Clin Lab; 2013; 59(5-6):589-96. PubMed ID: 23865358
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
